Health Care
Companies operating within the Health Care industry, ranked by market capitalization.
| Ticker | Exchange | Company Name | Last Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| BMRN | NASDAQ | Biomarin Pharmaceutical | $53.97 | -0.45% | 1M | $10.41B |
| EHC | NYSE | Encompass Health | $101.90 | -0.69% | 927K | $10.32B |
| MOH | NYSE | Molina Healthcare | $194.36 | -1.09% | 2M | $10.12B |
| MASI | NASDAQ | Masimo | $178.42 | -0.02% | 664K | $9.59B |
| ARWR | NASDAQ | Arrowhead Pharmaceuticals | $70.39 | -0.20% | 2M | $9.58B |
| RVTY | NYSE | Revvity | $83.83 | +1.90% | 1M | $9.33B |
| AXSM | NASDAQ | Axsome Therapeutics | $186.48 | +1.37% | 658K | $9.27B |
| ICLR | NASDAQ | Icon Plc | $114.13 | -1.76% | 3M | $9.03B |
| TEM | NASDAQ | Tempus AI | $52.66 | +5.28% | 4M | $8.9B |
| HSIC | NASDAQ | Henry Schein | $73.31 | -0.66% | 1M | $8.69B |
| BAX | NYSE | Baxter International | $16.69 | -1.27% | 8M | $8.69B |
| BTSG | NASDAQ | BrightSpring Health Services | $45.26 | -6.00% | 2M | $8.68B |
| BPMC | NASDAQ | Blueprint Medicines | $0.00 | 0.00% | NaN | $8.27B |
| TECH | NASDAQ | BioTechne | $52.88 | +1.80% | 2M | $8.09B |
| PRAX | NASDAQ | Praxis Precision Medicines | $321.66 | -0.47% | 368K | $8.08B |
| CRL | NYSE | Charles River Laboratories International | $163.91 | +0.04% | 774K | $8.06B |
| ABVX | NYSE EURONEXT - EURONEXT PARIS | Abivax | $109.06 | +2.65% | 748K | $7.75B |
| KRYS | NASDAQ | Krystal Biotech | $259.17 | -0.30% | 205K | $7.54B |
| PCVX | NASDAQ | Vaxcyte | $56.61 | -1.24% | 971K | $7.5B |
| BIO | NYSE | BioRad Laboratories | $278.16 | +1.09% | 300K | $7.42B |
| HALO | NASDAQ | Halozyme Therapeutics | $63.68 | +0.98% | 2M | $7.42B |
| QGEN | NYSE | Qiagen NV | $33.89 | +0.83% | 3M | $7.32B |
| CYTK | NASDAQ | Cytokinetics | $62.44 | +4.80% | 2M | $7.28B |
| NUVL | NASDAQ | Nuvalent | $99.58 | +0.48% | 650K | $7.21B |
| HQY | NASDAQ | Healthequity | $80.04 | -1.77% | 937K | $6.96B |
| IBRX | NASDAQ | ImmunityBio | $7.02 | +0.91% | 12M | $6.86B |
| GKOS | NYSE | Glaukos | $134.06 | +14.62% | 678K | $6.72B |
| ACLX | NASDAQ | Arcellx | $115.07 | +0.03% | 5M | $6.65B |
| RGEN | NASDAQ | Repligen | $113.72 | +0.54% | 1M | $6.37B |
| PTGX | NASDAQ | Protagonist Therapeutics | $97.60 | -0.93% | 732K | $6.16B |
| RCM | NASDAQ | R1 RCM | $0.00 | 0.00% | 0 | $6.04B |
| HIMS | NYSE | Hims & Hers Health | $25.82 | -1.94% | 31M | $5.99B |
| TFX | NYSE | Teleflex orporated | $124.10 | -6.90% | 861K | $5.89B |
| KYMR | NASDAQ | Kymera Therapeutics | $78.47 | -3.73% | 507K | $5.86B |
| CHE | NYSE | Chemed | $420.14 | -0.90% | 394K | $5.84B |
| CDTX | NASDAQ | Cidara Therapeutics | $0.00 | 0.00% | 0 | $5.61B |
| APGE | NASDAQ | Apogee Therapeutics | $83.30 | +1.55% | 692K | $5.6B |
| SYRE | NASDAQ | Spyre Therapeutics | $73.54 | +2.30% | 972K | $5.58B |
| ALKS | NASDAQ | Alkermes plc | $34.05 | +1.01% | 2M | $5.57B |
| CELC | NASDAQ | Celcuity | $119.76 | +0.64% | 886K | $5.51B |
| RYTM | NASDAQ | Rhythm Pharmaceuticals | $82.54 | +0.51% | 423K | $5.48B |
| BLCO | NYSE | Bausch + Lomb | $15.54 | +1.30% | 540K | $5.43B |
| BLTE | NASDAQ | Belite Bio | $155.76 | +0.82% | 77K | $5.39B |
| LNTH | NASDAQ | Lantheus Holdings | $81.30 | +0.16% | 801K | $5.38B |
| AVTR | NYSE | Avantor | $8.14 | +3.63% | 11M | $5.35B |
| TGTX | NASDAQ | TG Therapeutics | $33.95 | +1.09% | 2M | $5.33B |
| CNTA | NASDAQ | Centessa Pharmaceuticals plc | $39.42 | -0.08% | 2M | $5.3B |
| PACS | NYSE | PACS Group | $33.13 | -0.81% | 768K | $5.23B |
| CGON | NASDAQ | Cg Oncology | $65.87 | +1.72% | 727K | $5.22B |
| BRKR | NASDAQ | Bruker | $35.20 | +2.65% | 2M | $5.21B |